UBS Maintains a 'Buy' on Darden Restaurants (DRI); Raising Numbers as EPS Trends Improving
Tweet
Share
E-mailGet Alerts DRI Hot Sheet
Price: $156.51 +0.39%
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
UBS maintains a 'Buy' on Darden Restaurants (NYSE: DRI) price target raised from $48 to $54.
UBS analyst says, "We are raising our price target to $54 and our FY12 and FY13 EPS estimates from $3.60 and $4.00 to $3.61 (+5% YOY) and $4.10 (+14% YOY), respectively, to reflect better industry growth, food cost comparisons, and promotions. We are also increasing our blended F3Q same store sales (SSS) estimate from 2.2% to 2.7%. Despite lackluster F2Q results, we believe the February 24th analyst day should prove to be a more upbeat event due to strong fiscal 3Q trends and upcoming plans for OG."
For an analyst ratings summary and ratings history on Darden Restaurants click here. For more ratings news on Darden Restaurants click here.
Shares of Darden Restaurants closed at $49.22 yesterday.
UBS analyst says, "We are raising our price target to $54 and our FY12 and FY13 EPS estimates from $3.60 and $4.00 to $3.61 (+5% YOY) and $4.10 (+14% YOY), respectively, to reflect better industry growth, food cost comparisons, and promotions. We are also increasing our blended F3Q same store sales (SSS) estimate from 2.2% to 2.7%. Despite lackluster F2Q results, we believe the February 24th analyst day should prove to be a more upbeat event due to strong fiscal 3Q trends and upcoming plans for OG."
For an analyst ratings summary and ratings history on Darden Restaurants click here. For more ratings news on Darden Restaurants click here.
Shares of Darden Restaurants closed at $49.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Jiangsu Hengrui Medicine Co. Ltd (600276:CH) PT Lowered to RMB62 at HSBC
- Ping An Insurance (2318:HK) (PNGAY) PT Lowered to HK$42 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
